Stock Ratings / Consumer Discretionary / PASW / forecast

TLF (43) BIRD (37) NCI (42) BRIA (56) ⌘ Pro Terminal →

Ping An Biomedical Co. Ltd. (Class A) (PASW) 12-Month Stock Forecast & Price Target Cone

$5.00 -0.20% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Ping An Biomedical Co. Ltd. (Class A) (PASW) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $15.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-10.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PASW)Realized 20D OHLCV Swing Band: ±12.5%

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your PASW Position Size: $10,000

Shares at $5.00: 2000.0 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $3.48

$6,960

$-3,040 (-30.4%)

12M Consensus BaseTarget $4.46

$8,920

$-1,080 (-10.8%)

12M Bull Case BreakoutTarget $30.74

$61,480

+$51,480 (+514.8%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 9

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$5	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$29	69%	B
JP MorganUS Large-Cap Research	SELL	$4	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PASW)

✓Walkthrough of PASW's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PASW // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -20.38%📐 HORIZONTAL RANGE

2026-10-30O $5.33H $5.53L $4.30C $5.00VOL 62.3K

RES: $10.83SUP: $2.88SMA50: $5.15SMA200: $6.11

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PASW Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PASW Butterfly Map → + Track PASW →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PASW today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PASW. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PASW today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PASW)

Consumer Discretionary Rank #923 of 1011 ⚔️ TLF vs PASW Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (PASW vs. TLF, BIRD, NCI, BRIA)

Industry: Apparel (27 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Ping An Biomedical Co. Ltd. (Class A) (PASW) ranks #923 by composite RQD confidence (34/100, grade E) and #897 by equity capitalization ($15.6M). Within this direct 5-issuer industry benchmark cohort, NCI leads on earnings valuation at 153.8x trailing P/E, while NCI leads on capital efficiency and profitability with 2.6% ROIC and 36.9% gross margin. BRIA currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with PASW at 34/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PASW ACTIVE Ping An Biomedical Co. Ltd. (Class A)	E	34/100	—	2.8%	—	-0.20%	$15.6M	Benchmark Subject
TLF Tandy Leather Factory Inc.	D-	43/100	—	57.0%	-2.1%	+0.44%	$18.5M	/tlf-vs-pasw →
BIRD Smartbird Inc. (Class A)	D-	37/100	—	41.0%	-35.0%	-0.93%	$25.0M	/bird-vs-pasw →
NCI Neo-Concept International Group Holdings Limited (Class A)	D-	42/100	153.8x	36.9%	2.6%	-1.68%	$6.6M	/nci-vs-pasw →
BRIA BrilliA Inc (Class A)	D+	56/100	—	—	—	-4.11%	$42.9M	/bria-vs-pasw →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-09-30 • CIK 0001897532

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Ping An Biomedical Co. Ltd. (Class A) (PASW) reported GAAP revenue of $4.8M , GAAP net income of -$1.8M, operating cash flow of -$902.9K, and free cash flow of -$902.9K . On the balance sheet, PASW closed FY2025 with $9.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-09-30	$4.8M	-$1.8M	-$902.9K	-$902.9K	$9.6M	—

3. PASW Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PASW stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Ping An Biomedical Co. Ltd. (Class A) (NASDAQ: PASW) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $5.00 (-0.20% 1D, market cap $15.6M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, PASW ranks #923 in composite RQD confidence.

How does PASW compare to TLF and BIRD in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Apparel), PASW carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 2.8%, and ROIC of —. By comparison, TLF (Tandy Leather Factory Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -2.1%, cap $18.5M) and BIRD (Smartbird Inc. (Class A)) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $25.0M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PASW?

Per PASW's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001897532), Ping An Biomedical Co. Ltd. (Class A) generated $4.8M in revenue, -$1.8M in net income, and -$902.9K in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PASW trading relative to its 50-day, 200-day, and 52-week technical levels?

PASW last traded at $5.00 (-0.20% on volume of 64,106 shares), positioning the stock -2.91% below its 50-day simple moving average ($5.15) and -18.17% below its 200-day simple moving average ($6.11). Across its 52-week range of $3.07 to $29.28, PASW sits at the 7.4% percentile with a 14-day RSI of 51.7 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.37 to $5.63).

PASW Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is PASW's 12-month stock price target?

Ping An Biomedical Co. Ltd. (Class A) (PASW) carries a 12-month consensus base price target of $4.46 (-10.8% from $5.00), with a bull-case target of $30.74 and a bear-case floor of $3.48.

Is PASW stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates PASW E (Strong Sell — SELL) with an RQD Confidence score of 34/100.

Direct Sub-Reports: PASW RQD Cockpit PASW 12M Forecast PASW Earnings & Move PASW Dividends & DRIP PASW Insiders & 13F PASW Whale Options PASW Profit Sankey PASW News & Why